期刊文献+

硝苯地平缓释剂治疗轻中度高血压的疗效和药理探析 被引量:2

Efficacy and Pharmacological Analysis of Nifedipine Relievers in the Treatment of Mild-to-moderate Hypertension
下载PDF
导出
摘要 目的对硝苯地平缓释剂治疗轻中度高血压患者的疗效进行观察,并分析硝苯地平缓释剂的药理作用。方法收集我院106例轻中度高血压患者,根据患者住院尾号的奇偶数将其分为两组各53例,对照组患者服用常规硝苯地平缓释片,治疗组患者服用硝苯地平缓释剂,对比两组治疗疗效。结果治疗组患者血压恢复至参考值时间、用药时间、总治疗有效率以及不良反应率等指标对比差异具有统计学意义(P<0.05)。结论治疗轻中度高血压患者采用硝苯地平缓释剂,有助于增强疗效,减少不良反应。 Objective To observe and analyze the efficacy and pharmacological analysis of nifedipine relievers in the treatment of mild-to-moderate hypertension. Methods 106 cases in our hospital patients with mild to moderate hypertension,according to the tail number of the number of hospitalized patients were divided into two groups of odd 53 cases in the control group of patients taking conventional nifedipine treatment group patients taking nifedipine horizon release agent,compared two groups of treatment efficacy. Results Blood pressure treatment group returned to the reference value of the time,treatment time,the comparison between the total treatment efficiency and adverse reaction rate difference was significant(P〈0.05). Conclusion The treatment of mild to moderate hypertension treated with nifedipine agents,help to enhance the efficacy and reduce adverse reactions.
作者 傅丽琼
出处 《中国卫生标准管理》 2015年第28期88-89,共2页 China Health Standard Management
关键词 轻中度高血压 硝苯地平缓释剂 药理 疗效 With mild to moderate hypertension Nifedipine release agent Pharmacology Effect
  • 相关文献

参考文献4

二级参考文献18

  • 1Caliskan M,Caliskan Z,Gullu H,et al.Increased morning blood pressure surge and coronary microvascular dysfunction in patient with early stage hypertension[J].J Am Soc Hypertens,2014,8(9):652-659.
  • 2Hoshide S,Kario K.Early morning hypertensionmorning blood pressure surge[J].Nihon Rinsho,2014,72(8):1395-1399.
  • 3Turak O,Afsar B,Ozcan F,et al.Relationship between elevated morning blood pressure surge,uric acid,and cardiovascular outcomes in hypertensive patients[J].J Clin Hypertens(Greenwich),2014,16(7):530-535.
  • 4Yasam VR,Jakki SL,Natarajan J,et al.A novel vesicular transdermal delivery of nifedipine-preparation,characterization and in vitro/in-vivo evaluation[J].Drug Deliv,2014,9(2):10-13.
  • 5Yamada T,Nagata K,Cheng XW,et al.Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats[J].Eur J Pharmacol,2013,615(3):163-170.
  • 6Lupi-Herrera E,Sandoval J,Figueroa J,et al.Left and right ventricular pow er:outputs are the strongest hemodynamic correlates to allow identification of acute responders to vasodilator treatment in idiopathic pulmonary arterial hypertension[J]. Arch Cardiol M ex,2011,81(2):100-107.
  • 7Kuga K,Xu DZ,Ohtsuka M,et al.Comparison of daily antihypertensive effects of amlodipine and nifedipine coat-core using ambulatory blood pressure monitoring-utility of“hypobaric curve”and“hypobaric area”[J].Clin Exp Hypertens,2011,33(4):231-239.
  • 8Magee LA,Von Dadelszen P.The management of severe hypertension[J].Semin Perinatol,2009,33(3):138-142.
  • 9Kumaravelrajan R,Narayanan N,Suba V.Development and evaluation of controlled porosity osmotic pump for nifedipine and metoprolol combinatio[J].Lipids Health Dis,2011,11(10):49-51.
  • 10Hu D,Liu L,Li W.Efficacy and safety of valsartanamlodipine single-pill combination in 11,422 Chinese patients with hypertension:an observational study[J].Adv Ther,2014,31(7):762-775.

共引文献28

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部